Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05709977Completed
Randomised, open-label trial in allergic rhinitis (AR) (2 arms). Primary endpoint: Visual Analog Scale at 6 weeks. Started Apr 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05709977.